BIOCE. NEW 2023 DL-,0001
BIOCE. NEW 2023 DL-,0001
Aktie · US09072V6002 · BIOC · A3EG0A (XNCM)
Übersicht Finanzkennzahlen
Kein Kurs
n/a

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
- - - - -4,03 % -0,91 % -99,96 %

Firmenprofil zu BIOCE. NEW 2023 DL-,0001 Aktie

Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring to identify resistance mechanisms. The company offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer (NSCLC), gastric cancer, colorectal cancer, prostate cancer, pancreaticobiliary cancer, and ovarian cancer. It also provides cerebrospinal fluid tumor cell and ctDNA and ctRNA testing services to medical oncologists, neuro-oncologists, surgical oncologists, urologists, pulmonologists, pathologists, and other physicians; clinical trial and research services to pharmaceutical companies, biopharmaceutical companies and clinical research organizations; and RT-PCR testing services for COVID-19. The company has a collaboration with CLEARED4 to develop a system for tracking and managing COVID-19 testing requirements and test results for its customers; and with Protean BioDiagnostics, Inc. to research the ability of its Target Selector molecular assay to determine EGFR status in NSCLC patients. Biocept, Inc. was incorporated in 1997 and is headquartered in San Diego, California.

Unternehmensdaten

Name BIOCE. NEW 2023 DL-,0001
Firma Biocept, Inc.
Symbol BIOC
Website https://biocept.com
Heimatbörse XNCM Frankfurt
WKN A3EG0A
ISIN US09072V6002
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Diagnostics & Research
CEO Mr. Darrell Taylor Esq.
Land Vereinigte Staaten von Amerika
Währung EUR
Mitarbeiter 0,1 T
Adresse 9955 Mesa Rim Road, 92121 San Diego
IPO Datum 2014-02-05

Ticker Symbole

Name Symbol
NASDAQ BIOC

Weitere Aktien

Investoren die BIOCE. NEW 2023 DL-,0001 die halten, haben auch folgende Aktien im Depot:
INTESA SAN. 16-23 FLR
INTESA SAN. 16-23 FLR Anleihe
LB.HESS.-THR.IS.19/27
LB.HESS.-THR.IS.19/27 Anleihe
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025